ADiTx Therapeutics, Inc. (ADTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Amro Albanna
Employees:
60
11161 ANDERSON STREET, SUITE 105-10014, LOMA LINDA, CA 92354
909-488-0844

Aditxt, Inc. develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies.

Data derived from most recent annual or quarterly report
Market Cap 2.577 Million Shares Outstanding4.296 Million Avg 30-day Volume 122.631 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-6.04
Price to Revenue6.5419 Debt to Equity24.3189 EBITDA-23.121 Million
Price to Book Value90.5193 Operating Margin-2669.7495 Enterprise Value7.514 Million
Current Ratio0.329 EPS Growth0.883 Quick Ratio0.107
1 Yr BETA 0.2346 52-week High/Low 28.49 / 0.55 Profit Margin-2927.7923
Operating Cash Flow Growth9.7304 Altman Z-Score-29.4346 Free Cash Flow to Firm -17.661 Million
View SEC Filings from ADTX instead.

View recent insider trading info

ADiTx Therapeutics, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ADTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-07-21 by ALBANNA AMRO A.
  • 3: filed on 2022-02-03 by SHATZKES MATTHEW
  • 4: filed on 2021-11-12 by ALBANNA ROWENA
  • 4: filed on 2021-11-12 by SHABAHANG SHAHROKH
  • 4: filed on 2021-11-12 by FARLEY THOMAS J
  • 4: filed on 2021-10-01 by CHUNG LAUREN
  • 4: filed on 2021-10-01 by KIAIE NAMVAR
  • 4: filed on 2021-10-01 by BRADY BRIAN MICHAEL
  • 4: filed on 2021-10-01 by ANTHONY LAURA E
  • 4: filed on 2021-10-01 by RUNGE JEFFREY W.

    • Events (8k)

  • 8-K: filed on 2023-05-31:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-26:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-28:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ALBANNA AMRO A. CHIEF EXECUTIVE OFFICER

    • Officer
    		 1 2022-07-19 1

    SHATZKES MATTHEW CHIEF LEGAL OFFICER AND GC

    • Officer
    		 0 2022-01-28 0

    ANTHONY LAURA E

    • Director
    		 11,500 2021-09-29 0

    RUNGE JEFFREY W.

    • Director
    		 11,500 2021-09-29 0

    BRADY BRIAN MICHAEL

    • Director
    		 11,500 2021-09-29 0

    KIAIE NAMVAR

    • Director
    		 11,500 2021-09-29 0

    SHABAHANG SHAHROKH CHIEF INNOVATION OFFICER

    • Officer
    		 105,000 2021-07-22 0

    ALBANNA ROWENA CHIEF OPERATING OFFICER

    • Officer
    		 100,000 2021-07-22 0

    FARLEY THOMAS J CHIEF FINANCIAL OFFICER

    • Officer
    		 155,000 2021-07-22 0

    CHUNG LAUREN

    • Director
    		 28,000 2021-07-14 0

    PANKOVCIN CORINNE CHIEF FINANCIAL OFFICER

    • Officer
    		 169,220 2021-06-04 0

    MCLEOD ROSLAND FISHER

    • Director
    		 0 2020-07-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADITXT INC ADTX 2023-06-07 22:15:04 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 21:45:05 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 21:15:04 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 20:45:04 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 20:15:06 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 19:45:04 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 19:15:04 UTC -68.3719 73.4419 35000
    ADITXT INC ADTX 2023-06-07 18:45:04 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 18:15:03 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 17:45:05 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 17:15:04 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 16:45:03 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 16:15:04 UTC -68.7893 73.8593 35000
    ADITXT INC ADTX 2023-06-07 15:45:04 UTC -68.7893 73.8593 30000
    ADITXT INC ADTX 2023-06-07 15:15:04 UTC -68.7893 73.8593 30000
    ADITXT INC ADTX 2023-06-07 14:45:04 UTC -68.7893 73.8593 30000
    ADITXT INC ADTX 2023-06-07 14:15:03 UTC -68.7893 73.8593 30000
    ADITXT INC ADTX 2023-06-07 13:45:03 UTC -68.1963 73.2663 30000
    ADITXT INC ADTX 2023-06-07 13:15:04 UTC -68.1963 73.2663 30000
    ADITXT INC ADTX 2023-06-07 12:45:04 UTC -68.1963 73.2663 30000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments